You are here

CurePSP: Ask the Doctor #3 - June 11, 2020

CurePSP: Ask the Doctor #3 - June 11, 2020

CurePSP-Ask-Doc-June-2020.png

CurePSP will host its next “Ask the Doctor” webinar on Thursday, June 11, 2020, at 4:00 p.m. Eastern Daylight Time (1:00 p.m. Pacific).

CurePSP will host its next “Ask the Doctor” webinar on Thursday, June 11, 2020, at 4:00 p.m. Eastern Daylight Time (1:00 p.m. Pacific). Diseases to be covered include progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and corticobasal degeneration (CBD).

During this webinar, Lawrence I. Golbe, M.D., CurePSP's director of clinical affairs, will answer questions that are submitted during registration by patients and families. Know that Dr. Golbe cannot give any case-specific medical advice, however he will cover a significant amount of material that may answer your questions. Any medications that are referred to in this presentation should not be tried unless under the supervision of a licensed professional.

Joanna Teters, CurePSP’s community outreach and education coordinator, will serve as moderator. You also can email your questions to her at info@curepsp.org.

This webinar will be set up on Zoom Video Communications. Registration is required.

Watch the "Ask the Doctor" webinar from June 11, 2020, below:

Dr. Golbe, Emeritus Professor of Neurology at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ., is a leading clinical expert in PSP and related neurodegenerative conditions. He is the author of "A Clinician’s Guide to Progressive Supranuclear Palsy."

He graduated from Brown University and New York University School of Medicine and did residency training at NYU/Bellevue before assuming his current position in 1983. He was Acting Chair of his department from 2000 to 2003 and was Program Director of its neurology residency from 2003 to 2018. His research is in the clinical genetics, clinimetrics, and epidemiology of parkinsonian disorders.

In 1988 Dr. Golbe co-led the first studies of the prevalence and risk factors in PSP. He led the clinical portion of the project that in 1997 identified the first known Mendelian mutation causing Parkinson’s disease in the gene for alpha-synuclein.

Dr. Golbe devised the PSP Rating Scale, which since its publication in 2007 has become the standard clinical measure and treatment outcome marker for PSP world-wide. He has a referral practice for patients with PSP and CBD and conducts multiple ongoing research studies.

He has worked closely with CurePSP since 1992, presently as Director of Clinical Affairs, chair of its Medical Advisory Board, and a member of its Board of Directors.

CurePSP is a nonprofit organization working to increase awareness, advocate for patients and families, and fund research for devastating prime of life neurodegenerative diseases, including PSP. This is the third "Ask the Doctor" webinar.

Watch the "Ask the Doctor" webinar from April 6, 2020, below:

Watch the "Ask the Doctor" webinar from May 5, 2020, below: